128 related articles for article (PubMed ID: 38775462)
1. Major Pancreatic Resection Increases Bone Mineral Density Loss, Osteoporosis, and Fractures.
Khalilieh S; Iyer A; Hammelef E; Zohar N; Gorgov E; Yeo TP; Lavu H; Bowne W; Yeo CJ; Nevler A
Ann Surg; 2024 May; ():. PubMed ID: 38775462
[TBL] [Abstract][Full Text] [Related]
2. Utilization of DXA Bone Mineral Densitometry in Ontario: An Evidence-Based Analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2006; 6(20):1-180. PubMed ID: 23074491
[TBL] [Abstract][Full Text] [Related]
3. Summary of AHRQ's comparative effectiveness review of treatment to prevent fractures in men and women with low bone density or osteoporosis: update of the 2007 report.
Levis S; Theodore G
J Manag Care Pharm; 2012 May; 18(4 Suppl B):S1-15; discussion S13. PubMed ID: 22716221
[TBL] [Abstract][Full Text] [Related]
4. Calcium and vitamin D for increasing bone mineral density in premenopausal women.
Méndez-Sánchez L; Clark P; Winzenberg TM; Tugwell P; Correa-Burrows P; Costello R
Cochrane Database Syst Rev; 2023 Jan; 1(1):CD012664. PubMed ID: 36705288
[TBL] [Abstract][Full Text] [Related]
5. Comparative efficacy of bone anabolic therapies in women with postmenopausal osteoporosis: A systematic review and network meta-analysis of randomized controlled trials.
Hernandez AV; Pérez-López FR; Piscoya A; Pasupuleti V; Roman YM; Thota P; Herrera A
Maturitas; 2019 Nov; 129():12-22. PubMed ID: 31547908
[TBL] [Abstract][Full Text] [Related]
6. Treatment of postmenopausal osteoporosis with bone-forming and antiresorptive treatments: Combined and sequential approaches.
Langdahl B
Bone; 2020 Oct; 139():115516. PubMed ID: 32622871
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological interventions versus placebo, no treatment or usual care for osteoporosis in people with chronic kidney disease stages 3-5D.
Hara T; Hijikata Y; Matsubara Y; Watanabe N
Cochrane Database Syst Rev; 2021 Jul; 7(7):CD013424. PubMed ID: 34231877
[TBL] [Abstract][Full Text] [Related]
8. Treatment for osteoporosis in people with beta-thalassaemia.
Bhardwaj A; Swe KMM; Sinha NK
Cochrane Database Syst Rev; 2023 May; 5(5):CD010429. PubMed ID: 37159055
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness and safety of vitamin D in relation to bone health.
Cranney A; Horsley T; O'Donnell S; Weiler H; Puil L; Ooi D; Atkinson S; Ward L; Moher D; Hanley D; Fang M; Yazdi F; Garritty C; Sampson M; Barrowman N; Tsertsvadze A; Mamaladze V
Evid Rep Technol Assess (Full Rep); 2007 Aug; (158):1-235. PubMed ID: 18088161
[TBL] [Abstract][Full Text] [Related]
10. Abaloparatide effect on forearm bone mineral density and wrist fracture risk in postmenopausal women with osteoporosis.
Watts NB; Hattersley G; Fitzpatrick LA; Wang Y; Williams GC; Miller PD; Cosman F
Osteoporos Int; 2019 Jun; 30(6):1187-1194. PubMed ID: 30899994
[TBL] [Abstract][Full Text] [Related]
11. Is There an Association Between Bone Microarchitecture and Fracture in Patients who were Treated for High-grade Osteosarcoma? A Controlled Study at Long-term Follow-up Using High-resolution Peripheral Quantitative CT.
Holzer G; Hobusch G; Hansen S; Fischer L; Patsch JM
Clin Orthop Relat Res; 2021 Nov; 479(11):2493-2501. PubMed ID: 34077400
[TBL] [Abstract][Full Text] [Related]
12. The change of bone mineral density and bone metabolism after gastrectomy for gastric cancer: a meta-analysis.
Oh HJ; Yoon BH; Ha YC; Suh DC; Lee SM; Koo KH; Lee YK
Osteoporos Int; 2020 Feb; 31(2):267-275. PubMed ID: 31776636
[TBL] [Abstract][Full Text] [Related]
13. Osteoporosis in lung transplantation candidates with end-stage pulmonary disease.
Shane E; Silverberg SJ; Donovan D; Papadopoulos A; Staron RB; Addesso V; Jorgesen B; McGregor C; Schulman L
Am J Med; 1996 Sep; 101(3):262-9. PubMed ID: 8873487
[TBL] [Abstract][Full Text] [Related]
14. Low Bone Mineral Density and Risk for Osteoporotic Fractures in Patients with Chronic Pancreatitis.
Vujasinovic M; Nezirevic Dobrijevic L; Asplund E; Rutkowski W; Dugic A; Kahn M; Dahlman I; Sääf M; Hagström H; Löhr JM
Nutrients; 2021 Jul; 13(7):. PubMed ID: 34371899
[No Abstract] [Full Text] [Related]
15. Denosumab, raloxifene, romosozumab and teriparatide to prevent osteoporotic fragility fractures: a systematic review and economic evaluation.
Davis S; Simpson E; Hamilton J; James MM; Rawdin A; Wong R; Goka E; Gittoes N; Selby P
Health Technol Assess; 2020 Jun; 24(29):1-314. PubMed ID: 32588816
[TBL] [Abstract][Full Text] [Related]
16. Denosumab and teriparatide transitions in postmenopausal osteoporosis (the DATA-Switch study): extension of a randomised controlled trial.
Leder BZ; Tsai JN; Uihlein AV; Wallace PM; Lee H; Neer RM; Burnett-Bowie SA
Lancet; 2015 Sep; 386(9999):1147-55. PubMed ID: 26144908
[TBL] [Abstract][Full Text] [Related]
17. Effects of teriparatide in Chinese and Caucasian women with osteoporosis: bridging study on efficacy.
Xie Z; Chen Y; Gurbuz S; Zhang B; Li Y; Bai F; Chen Y
Clin Interv Aging; 2019; 14():959-968. PubMed ID: 31213783
[TBL] [Abstract][Full Text] [Related]
18. Screening for the primary prevention of fragility fractures among adults aged 40 years and older in primary care: systematic reviews of the effects and acceptability of screening and treatment, and the accuracy of risk prediction tools.
Gates M; Pillay J; Nuspl M; Wingert A; Vandermeer B; Hartling L
Syst Rev; 2023 Mar; 12(1):51. PubMed ID: 36945065
[TBL] [Abstract][Full Text] [Related]
19. The clinician's guide to prevention and treatment of osteoporosis.
LeBoff MS; Greenspan SL; Insogna KL; Lewiecki EM; Saag KG; Singer AJ; Siris ES
Osteoporos Int; 2022 Oct; 33(10):2049-2102. PubMed ID: 35478046
[TBL] [Abstract][Full Text] [Related]
20. Bisphosphonates for steroid-induced osteoporosis.
Allen CS; Yeung JH; Vandermeer B; Homik J
Cochrane Database Syst Rev; 2016 Oct; 10(10):CD001347. PubMed ID: 27706804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
